Resmed Inc
RMD252.270USD
-0.040-0.02%
Handelsschluss 12/12, 16:00（ET）Kurse um 15 Minuten verzögert
36.82BMarktkapitalisierung
25.71KGV TTM
mehr Informationen über Resmed Inc Unternehmen
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Resmed Inc Informationen
BörsenkürzelRMD
Name des UnternehmensResmed Inc
IPO-datumJun 01, 1995
CEOFarrell (Michael J)
Anzahl der mitarbeiter10600
WertpapierartOrdinary Share
GeschäftsjahresendeJun 01
Addresse9001 Spectrum Center Blvd
StadtSAN DIEGO
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl92123
Telefon18587462400
Websitehttps://www.resmed.com/
BörsenkürzelRMD
IPO-datumJun 01, 1995
CEOFarrell (Michael J)
Führungskräfte von Resmed Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Brett A. Sandercock
Mr. Brett A. Sandercock
Chief Financial Officer
Chief Financial Officer
79.62K
-1.24%
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.53%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+6.05%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+10.45%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+11.26%
Dr. Desney Tan
Dr. Desney Tan
Independent Director
Independent Director
6.00K
+21.77%
Ms. Nicole Mowad-Nassar
Ms. Nicole Mowad-Nassar
Independent Director
Independent Director
--
--
Mr. John B. Hernandez
Mr. John B. Hernandez
Independent Director
Independent Director
--
--
Mr. Justin M. W. Leong
Mr. Justin M. W. Leong
Chief Product Officer
Chief Product Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Brett A. Sandercock
Mr. Brett A. Sandercock
Chief Financial Officer
Chief Financial Officer
79.62K
-1.24%
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.53%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+6.05%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+10.45%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+11.26%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Devices
2.67B
51.79%
Masks and other
1.84B
35.75%
Nach RegionUSD
Name
Umsatz
Anteil
United States
3.29B
63.84%
Rest of the world
1.86B
36.16%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Devices
2.67B
51.79%
Masks and other
1.84B
35.75%
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
13.00%
BlackRock Institutional Trust Company, N.A.
5.92%
State Street Investment Management (US)
4.49%
Geode Capital Management, L.L.C.
2.91%
Walter Scott & Partners Ltd.
1.93%
Andere
71.75%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
13.00%
BlackRock Institutional Trust Company, N.A.
5.92%
State Street Investment Management (US)
4.49%
Geode Capital Management, L.L.C.
2.91%
Walter Scott & Partners Ltd.
1.93%
Andere
71.75%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
38.50%
Investment Advisor/Hedge Fund
19.36%
Pension Fund
2.46%
Research Firm
2.24%
Bank and Trust
1.37%
Sovereign Wealth Fund
0.88%
Hedge Fund
0.77%
Individual Investor
0.51%
Corporation
0.11%
Andere
33.79%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
1773
95.81M
65.64%
-3.83M
2025Q2
1772
96.52M
65.83%
-8.52M
2025Q1
1781
97.60M
66.56%
-6.39M
2024Q4
1734
93.56M
63.70%
-7.66M
2024Q3
1652
90.85M
61.90%
-10.07M
2024Q2
1605
89.55M
60.95%
-7.66M
2024Q1
1565
87.15M
59.25%
-8.40M
2023Q4
1535
84.78M
57.62%
-16.98M
2023Q3
1539
92.21M
62.70%
-12.21M
2023Q2
1526
99.54M
67.75%
-3.05M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
18.68M
12.8%
+250.83K
+1.36%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
8.67M
5.94%
-214.00K
-2.41%
Jun 30, 2025
State Street Investment Management (US)
6.62M
4.53%
+64.45K
+0.98%
Jun 30, 2025
Geode Capital Management, L.L.C.
4.22M
2.89%
+98.72K
+2.40%
Jun 30, 2025
Walter Scott & Partners Ltd.
3.29M
2.25%
-73.30K
-2.18%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
1.19M
0.81%
+669.17K
+129.03%
Jun 30, 2025
Northern Trust Investments, Inc.
1.17M
0.8%
-944.00
-0.08%
Jun 30, 2025
Invesco Capital Management LLC
1.16M
0.8%
-30.11K
-2.52%
Jun 30, 2025
BlackRock Asset Management Ireland Limited
1.13M
0.77%
+46.73K
+4.31%
Jun 30, 2025
Charles Schwab Investment Management, Inc.
1.02M
0.7%
+22.87K
+2.29%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
Langar Global HealthTech ETF
9.06%
First Trust Nasdaq Lux Digi Health Solutions ETF
7.21%
Pacer US Cash Cows Growth ETF
4.31%
iShares U.S. Medical Devices ETF
4.09%
Global X HealthTech ETF
4.02%
ERShares Entrepreneurs ETF
2.49%
Siren DIVCON Dividend Defender ETF
2.22%
SEI Enhanced US Large Cap Quality Factor ETF
1.92%
First Trust Growth Strength ETF
1.83%
First Trust Indxx Medical Devices ETF
1.82%
Mehr Anzeigen
Langar Global HealthTech ETF
Anteil9.06%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil7.21%
Pacer US Cash Cows Growth ETF
Anteil4.31%
iShares U.S. Medical Devices ETF
Anteil4.09%
Global X HealthTech ETF
Anteil4.02%
ERShares Entrepreneurs ETF
Anteil2.49%
Siren DIVCON Dividend Defender ETF
Anteil2.22%
SEI Enhanced US Large Cap Quality Factor ETF
Anteil1.92%
First Trust Growth Strength ETF
Anteil1.83%
First Trust Indxx Medical Devices ETF
Anteil1.82%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
1.32B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jan 30, 2025
RMD.NB Interim Cash Dividend of gross USD 0.53 paid on Mar 20, 2025 going ex on Feb 13, 2025
Feb 13, 2025
Mar 20, 2025
Feb 13, 2025
Oct 25, 2024
RMD.NB Interim Cash Dividend of gross USD 0.53 paid on Dec 12, 2024 going ex on Nov 07, 2024
Nov 07, 2024
Dec 12, 2024
Nov 07, 2024
Aug 01, 2024
RMD.NB Final Cash Dividend of gross USD 0.53 paid on Sep 19, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 19, 2024
Aug 15, 2024
Apr 25, 2024
RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Jun 13, 2024 going ex on May 08, 2024
May 09, 2024
Jun 13, 2024
May 08, 2024
Jan 25, 2024
RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Mar 14, 2024 going ex on Feb 07, 2024
Feb 08, 2024
Mar 14, 2024
Feb 07, 2024
Oct 27, 2023
RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Dec 14, 2023 going ex on Nov 08, 2023
Nov 09, 2023
Dec 14, 2023
Nov 08, 2023
Aug 03, 2023
RMD.NB Final Cash Dividend of gross USD 0.48 paid on Sep 21, 2023 going ex on Aug 16, 2023
Aug 17, 2023
Sep 21, 2023
Aug 16, 2023
Apr 28, 2023
RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Jun 15, 2023 going ex on May 10, 2023
May 11, 2023
Jun 15, 2023
May 10, 2023
Jan 27, 2023
RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Mar 16, 2023 going ex on Feb 08, 2023
Feb 09, 2023
Mar 16, 2023
Feb 08, 2023
Oct 27, 2022
RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Dec 15, 2022 going ex on Nov 09, 2022
Nov 10, 2022
Dec 15, 2022
Nov 09, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Resmed Inc?
Die fünf größten Anteilseigner von Resmed Inc sind:
The Vanguard Group, Inc. hält 18.68M Aktien, was 12.80% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 8.67M Aktien, was 5.94% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 6.62M Aktien, was 4.53% der Gesamtaktien entspricht.
Geode Capital Management, L.L.C. hält 4.22M Aktien, was 2.89% der Gesamtaktien entspricht.
Walter Scott & Partners Ltd. hält 3.29M Aktien, was 2.25% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 18.68M Aktien, was 12.80% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 8.67M Aktien, was 5.94% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 6.62M Aktien, was 4.53% der Gesamtaktien entspricht.
Geode Capital Management, L.L.C. hält 4.22M Aktien, was 2.89% der Gesamtaktien entspricht.
Walter Scott & Partners Ltd. hält 3.29M Aktien, was 2.25% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Resmed Inc?
Die drei wichtigsten Anteilseigner-Typen von Resmed Inc sind:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Wie viele Institutionen halten Anteile an Resmed Inc (RMD)?
Mit Stand vom 2025Q3 halten 1773 Institutionen Anteile an Resmed Inc, mit einem Gesamtmarktwert von etwa 95.81M, was 65.64% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um -0.19% gestiegen.
Was ist die größte Einnahmequelle von Resmed Inc?
Am FY2025 erzielte das Geschäft mit Devices für Resmed Inc den höchsten Umsatz in Höhe von 2.67B, was 51.79% des Gesamtumsatzes entspricht.
